Biology Reference
In-Depth Information
Wharton J, Strange JW, Moller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR
(2005) Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary
artery cells. Am J Respir Crit Care Med 172:105-113
Wiggs BR, Moreno R, Hogg JC, Hilliam C, Pare PD (1990) A model of the mechanics of airway
narrowing. J Appl Physiol 69:849-860
Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW (2001)
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
Circulation 104:1218-1222
Wilsmhurst PT, Webb-Peploe MM (1983) Side effects of amrinone therapy. Br Heart J 49:447-451
Wilson SM, Shen P, Rider CF, Traves SL, Proud D, Newton R, Giembycz MA (2009) Selective
prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human
bronchial epithelial cells. J Immunol 183:6788-6799
Woodrow MD, Ballantine SP, Barker MD, Clarke BJ, Dawson J, Dean TW, Delves CJ, Evans B,
Gough SL, Guntrip SB, Holman S, Holmes DS, Kranz M, Lindvaal MK, Lucas FS, Neu M,
Ranshaw LE, Solanke YE, Somers DO, Ward P, Wiseman JO (2009) Quinolines as a
novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled
administration. Bioorg Med Chem Lett 19:5261-5265
Woodruff PG, Dolganov GM, Ferrando RE, Donnelly S, Hays SR, Solberg OD, Carter R, Wong HH,
Cadbury PS, Fahy JV (2004) Hyperplasia of smooth muscle in mild to moderate asthma without
changes in cell size or gene expression. Am J Respir Crit Care Med 169:1001-1006
Wright LC, Seybold J, Robichaud A, Adcock IM, Barnes PJ (1998) Phosphodiesterase expression
in human epithelial cells. Am J Physiol 275:L694-L700
Yamamoto S, Sugahara S, Ikeda K, Shimizu Y (2006a) Pharmacological profile of a novel
phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation
models. Eur J Pharmacol 550:166-172
Yamamoto S, Sugahara S, Naito R, Ichikawa A, Ikeda K, Yamada T, Shimizu Y (2006b) The
effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related
cytokine production in vitro and in vivo. Eur J Pharmacol 541:106-114
Yamamoto S, Sugahara S, Ikeda K, Shimizu Y (2007a) Amelioration of collagen-induced arthritis
in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059. Eur J Pharmacol
559:219-226
Yamamoto T, Shimano H, Inoue N, Nakagawa Y, Matsuzaka T, Takahashi A, Yahagi N, Sone H,
Suzuki H, Toyoshima H, Yamada N (2007b) Protein kinase A suppresses sterol regulatory
element-binding protein-1C expression via phosphorylation of liver X receptor in the liver.
J Biol Chem 282:11687-11695
Yamashita K, Kobayashi S, Okada K, Tsunematsu T (1990) Increased external carotid artery blood
flow in headache patients induced by cilostazol. Preliminary communication. Arzneimittel-
forschung 40:587-588
Yang G, McIntyre KW, Townsend RM, Shen HH, Pitts WJ, Dodd JH, Nadler SG, McKinnon M,
Watson AJ (2003) Phosphodiesterase 7A-deficient mice have functional T cells. J Immunol
171:6414-6420
Ye RD (2000) b -Adrenergic agonists regulate NF- k B activation through multiple mechanisms.
Am J Physiol Lung Cell Mol Physiol 279:L615-L617
Yu SM, Tsai SY, Kuo SC, Ou JT (1996) Inhibition of platelet function by A02131-1, a novel
inhibitor of cGMP-specific phosphodiesterase, in vitro and in vivo. Blood 87:3758-3767
Zhang L, Insel PA (2004) The pro-apoptotic protein Bim is a convergence point for cAMP/protein
kinase A- and glucocorticoid-promoted apoptosis of
lymphoid cells.
J Biol Chem
279:20858-20865
Zhang YK, Plattner JJ, Akama T, Baker SJ, Hernandez VS, Sanders V, Freund Y, Kimura R,
Bu W, Hold KM, Lu XS (2010) Design and synthesis of boron-containing PDE4 inhibitors
using soft-drug strategy for potential dermatologic anti-inflammatory application. Bioorg Med
Chem Lett 20:2270-2274
Search WWH ::




Custom Search